BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2848217)

  • 1. Effects of VM26, a specific inhibitor of type II DNA topoisomerase, on SV40 chromatin replication in vitro.
    Richter A; Strausfeld U
    Nucleic Acids Res; 1988 Nov; 16(21):10119-29. PubMed ID: 2848217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of VM26 (teniposide), a specific inhibitor of type II DNA topoisomerase, on SV40 DNA replication in vivo.
    Richter A; Strausfeld U; Knippers R
    Nucleic Acids Res; 1987 Apr; 15(8):3455-68. PubMed ID: 3033604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of topoisomerase I or II may lead to recombination or to aberrant replication termination on both SV40 and yeast 2 micron DNA.
    Levac P; Moss T
    Chromosoma; 1996 Oct; 105(4):250-60. PubMed ID: 8854885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase I and II cleavage of adenovirus DNA in vivo: both topoisomerase activities appear to be required for adenovirus DNA replication.
    Schaack J; Schedl P; Shenk T
    J Virol; 1990 Jan; 64(1):78-85. PubMed ID: 2152835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA topoisomerase II is required for formation of mitotic chromosomes in Chinese hamster ovary cells: studies using the inhibitor 4'-demethylepipodophyllotoxin 9-(4,6-O-thenylidene-beta-D-glucopyranoside).
    Charron M; Hancock R
    Biochemistry; 1990 Oct; 29(41):9531-7. PubMed ID: 2176848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of DNA synthesis by aphidicolin induces supercoiling in simian virus 40 replicative intermediates.
    Dröge P; Sogo JM; Stahl H
    EMBO J; 1985 Dec; 4(12):3241-6. PubMed ID: 3004946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the DNA catenation activity of type II topoisomerase by VP16-213 and VM26.
    Minocha A; Long BH
    Biochem Biophys Res Commun; 1984 Jul; 122(1):165-70. PubMed ID: 6331440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topoisomerase II plays an essential role as a swivelase in the late stage of SV40 chromosome replication in vitro.
    Ishimi Y; Sugasawa K; Hanaoka F; Eki T; Hurwitz J
    J Biol Chem; 1992 Jan; 267(1):462-6. PubMed ID: 1309747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ICRF-193, a novel DNA topoisomerase II inhibitor, on simian virus 40 DNA and chromosome replication in vitro.
    Ishimi Y; Ishida R; Andoh T
    Mol Cell Biol; 1992 Sep; 12(9):4007-14. PubMed ID: 1324412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the DNA topoisomerase II inhibitor, VM26, on transcriptional initiation in vitro.
    Preston GM; White BA
    Life Sci; 1990; 46(18):1309-18. PubMed ID: 2161065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topoisomerase inhibitors can selectively interfere with different stages of simian virus 40 DNA replication.
    Snapka RM
    NCI Monogr; 1987; (4):55-60. PubMed ID: 2819732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin.
    Hsiang YH; Lihou MG; Liu LF
    Cancer Res; 1989 Sep; 49(18):5077-82. PubMed ID: 2548710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of DNA topoisomerases in simian virus 40 DNA replication in vitro.
    Yang L; Wold MS; Li JJ; Kelly TJ; Liu LF
    Proc Natl Acad Sci U S A; 1987 Feb; 84(4):950-4. PubMed ID: 3029765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of drug accumulation and DNA topoisomerase II activity in acquired teniposide-resistant human cancer KB cell lines.
    Matsuo K; Kohno K; Takano H; Sato S; Kiue A; Kuwano M
    Cancer Res; 1990 Sep; 50(18):5819-24. PubMed ID: 2168282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase I is preferentially associated with normal SV40 replicative intermediates, but is associated with both replicating and nonreplicating SV40 DNAs which are deficient in histones.
    Champoux JJ
    Nucleic Acids Res; 1992 Jul; 20(13):3347-52. PubMed ID: 1321412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SV40 DNA replication intermediates: analysis of drugs which target mammalian DNA replication.
    Snapka RM; Permana PA
    Bioessays; 1993 Feb; 15(2):121-7. PubMed ID: 8385943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered formation of DNA in human cells treated with inhibitors of DNA topoisomerase II (etoposide and teniposide).
    Lönn U; Lönn S; Nylen U; Winblad G
    Cancer Res; 1989 Nov; 49(22):6202-7. PubMed ID: 2553248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topoisomerase II inhibitors influence simian virus 40 chromatin structure in vivo accompanied with inhibition of replication, transcription and changes in DNA supercoiling.
    Waldeck W; Zentgraf H; Rösl F
    Oncology; 1988; 45(2):107-16. PubMed ID: 2832799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of simian virus 40 into cellular DNA occurs at or near topoisomerase II cleavage hot spots induced by VM-26 (teniposide).
    Bodley AL; Huang HC; Yu C; Liu LF
    Mol Cell Biol; 1993 Oct; 13(10):6190-200. PubMed ID: 8413219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accessibility to topoisomerases I and II regulates the replication efficiency of simian virus 40 minichromosomes.
    Halmer L; Gruss C
    Mol Cell Biol; 1997 May; 17(5):2624-30. PubMed ID: 9111332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.